ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that the Welsh Ambulance Services (WAST) NHS is equipping its frontline ambulances with the ZOLL E Series® EMS monitor/defibrillator. Under the terms of the agreement, ZOLL plans to supply a total of 185 E Series units for distribution to the north, central and west, and southeast regions of the Welsh Service.
“And throughout our relationship with ZOLL, we've come to rely on them for excellent customer service.”
This contract, valued at $1.7 million (U.S.), is the largest order to date for the E Series in the United Kingdom. A ZOLL customer for 12 years, WAST is standardized on the Company's monitor/defibrillator products and updated to the E Series two years ago when it purchased 54 E Series units.
"From the outset, we've been impressed with the impact the full-featured E Series offers in improving outcomes from sudden cardiac arrest. The 12-lead STEMI option gives us the ability to simultaneously share information with the ED so they are prepared when the patient arrives," said a WAST spokesperson. "And throughout our relationship with ZOLL, we've come to rely on them for excellent customer service."
"ZOLL is pleased that the Welsh Ambulance Service Trust continues to use ZOLL as a partner in its mission to offer the best critical care for Welsh citizens. This upgrade of equipment demonstrates the value they place on advancing resuscitation care and we are pleased they continue to use ZOLL as a partner to help save more lives," said Jonathan A. Rennert, President of ZOLL.
Study tests the feasibility of drone-delivered AEDs for out-of-hospital cardiac arrest